Human epidermal growth factor receptor 2 (HER2)-positive (+) breast cancer (BC) is a subtype of breast cancer where amplification of the HER2 gene results in HER2 receptor overexpression, which is a major driver of tumor development and progression (1). This evidence concerns the gene ERBB2 and breast cancer.